GlassScriptPhysician profile
Amy E Schlaifer
NPI 1366615676
$7,981.56
in general payments reported to CMS, 2019-2025
38 companies · $1,253 in 2025
The $1,253 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $765 · 2020: $1,205 · 2021: $1,670 · 2022: $2,109 · 2023: $410 · 2024: $569 · 2025: $1,253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,205 · Education: $27.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,204.78 |
| Education | $27.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,484.34 | 2021-2023 | Axonics, Bulkamid |
| Valencia Technologies Corporation | $1,320.65 | 2022 | |
| Caldera Medical, INC | $870.12 | 2019-2023 | Desara |
| Neotract INC. | $738.97 | 2019-2020 | |
| Medtronic, INC. | $452.08 | 2022-2025 | Altaviva |
| Boston Scientific Corporation | $306.74 | 2019-2024 | Ams 700 |
| Coloplast Corp | $273.28 | 2019-2025 | Titan |
| Sumitomo Pharma America, INC. | $235.11 | 2023-2025 | Gemtesa, Orgovyx |
| 180 Medical, INC. | $233.58 | 2019-2025 | Gentlecath, Gentlecath Glide |
| Procept Biorobotics Corporation | $225.18 | 2022-2025 | |
| Laborie Medical Technologies Corp. | $195.37 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Teleflex LLC | $168.90 | 2021-2024 | Solesta, Urolift |
| Endo Pharmaceuticals INC. | $135.45 | 2020 | |
| Dornier Medtech America, INC | $133.02 | 2025 | Dornier Medtech |
| Calyxo, INC. | $128.25 | 2025 | Cvac Aspiration System |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $99.39 | 2024-2025 | Keytruda |
| Bluewind Medical | $88.15 | 2025 | |
| Angiodynamics, INC. | $87.29 | 2025 | Nanoknife |
| Urogen Pharma, INC. | $80.26 | 2022-2025 | |
| Astellas Pharma US INC | $71.09 | 2019 | |
| Progenics Pharmaceuticals, INC. | $58.31 | 2023-2024 | Pylarify |
| Myriad Genetic Laboratories, INC. | $56.52 | 2020-2022 | |
| Janssen Biotech, INC. | $52.47 | 2023-2025 | Erleada |
| Accord Healthcare, INC. | $49.77 | 2023 | |
| Lucid Diagnostics INC. | $45.91 | 2022 | |
| Histosonics, INC. | $41.99 | 2025 | |
| Baxter Healthcare | $40.07 | 2025 | Floseal |
| Pfizer INC. | $37.19 | 2019-2025 | |
| Blue Earth Diagnostics | $34.39 | 2025 | Posluma |
| Verity Pharmaceuticals INC. | $34.29 | 2024 | Tlando |
| Smith+Nephew, INC. | $31.38 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $28.98 | 2021 | |
| Daiichi Sankyo INC. | $28.76 | 2025 | Enhertu |
| Medtronic USA, INC. | $27.11 | 2020 | |
| Ferring Pharmaceuticals INC. | $26.44 | 2024 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $22.84 | 2025 | |
| Tolmar, INC. | $21.44 | 2023 | |
| Abbvie INC. | $16.48 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Schlaifer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.